Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1990 Apr;85(4):1173–1181. doi: 10.1172/JCI114550

Hydroxyeicosatetraenoic acid metabolism in cultured human skin fibroblasts. Evidence for peroxisomal beta-oxidation.

J A Gordon 1, P H Figard 1, A A Spector 1
PMCID: PMC296549  PMID: 2318972

Abstract

To determine whether the peroxisome is responsible for hydroxyeicosatetraenoic acid (HETE) oxidation, 12- and 15-HETE oxidation was measured in normal and peroxisomal deficient skin fibroblasts from patients with Zellweger's (cerebrohepatorenal) syndrome. When incubated for 1 h with normal fibroblasts, reverse phase HPLC indicated that 24% of the 12-HETE radioactivity was converted to one major polar metabolite. Chemical derivatization followed by reverse phase HPLC and TLC indicated that this metabolite is 8-hydroxyhexadecatrienoic acid [16:3(8-OH)]. Similarly, 33% of the added 15-HETE was also converted to a more polar metabolite. Neither 12- nor 15-HETE were converted to any metabolites by the peroxisomal deficient (Zellweger) cells. No defect in HETE oxidation was found in other human fibroblast cell lines with diverse metabolic abnormalities. Zellweger fibroblasts accumulated increased amounts of 12-HETE, compared with normal fibroblasts. As in the normal cells, most of the 12-HETE incorporated into Zellweger fibroblasts was present in the choline and ethanolamine phosphoglycerides. Protein synthesis, lysosomal acid lipase activity, and mitochondrial butyrate oxidation were not impaired in the Zellweger fibroblasts. Since the Zellweger cells do not convert 12- and 15-HETE to oxidative metabolites, peroxisomes appear to be the cellular organelle responsible for HETE oxidation.

Full text

PDF
1173

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bremer J., Norum K. R. Metabolism of very long-chain monounsaturated fatty acids (22:1) and the adaptation to their presence in the diet. J Lipid Res. 1982 Feb;23(2):243–256. [PubMed] [Google Scholar]
  2. Diczfalusy U., Alexson S. E., Pedersen J. I. Chain-shortening of prostaglandin F2 alpha by rat liver peroxisomes. Biochem Biophys Res Commun. 1987 May 14;144(3):1206–1213. doi: 10.1016/0006-291x(87)91439-2. [DOI] [PubMed] [Google Scholar]
  3. Goetzl E. J., Woods J. M., Gorman R. R. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. J Clin Invest. 1977 Jan;59(1):179–183. doi: 10.1172/JCI108617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goldfischer S., Moore C. L., Johnson A. B., Spiro A. J., Valsamis M. P., Wisniewski H. K., Ritch R. H., Norton W. T., Rapin I., Gartner L. M. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science. 1973 Oct 5;182(4107):62–64. doi: 10.1126/science.182.4107.62. [DOI] [PubMed] [Google Scholar]
  5. Gordon J. A., Figard P. H., Spector A. A. Identification of the major metabolite of 12-HETE produced by renal tubular epithelial cells. J Lipid Res. 1989 May;30(5):731–738. [PubMed] [Google Scholar]
  6. Gordon J. A., Spector A. A. Effects of 12-HETE on renal tubular epithelial cells. Am J Physiol. 1987 Aug;253(2 Pt 1):C277–C285. doi: 10.1152/ajpcell.1987.253.2.C277. [DOI] [PubMed] [Google Scholar]
  7. Hadjiagapiou C., Spector A. A. 12-Hydroxyeicosatetraenoic acid reduces prostacyclin production by endothelial cells. Prostaglandins. 1986 Jun;31(6):1135–1144. doi: 10.1016/0090-6980(86)90215-7. [DOI] [PubMed] [Google Scholar]
  8. Hadjiagapiou C., Sprecher H., Kaduce T. L., Figard P. H., Spector A. A. Formation of 8-hydroxyhexadecatrienoic acid by vascular smooth muscle cells. Prostaglandins. 1987 Oct;34(4):579–589. doi: 10.1016/0090-6980(87)90100-6. [DOI] [PubMed] [Google Scholar]
  9. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3400–3404. doi: 10.1073/pnas.71.9.3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hiltunen J. K., Kärki T., Hassinen I. E., Osmundsen H. beta-Oxidation of polyunsaturated fatty acids by rat liver peroxisomes. A role for 2,4-dienoyl-coenzyme A reductase in peroxisomal beta-oxidation. J Biol Chem. 1986 Dec 15;261(35):16484–16493. [PubMed] [Google Scholar]
  11. Hruban Z., Vigil E. L., Slesers A., Hopkins E. Microbodies: constituent organelles of animal cells. Lab Invest. 1972 Aug;27(2):184–191. [PubMed] [Google Scholar]
  12. Johnson H. G., McNee M. L., Sun F. F. 15-Hydroxyeicosatetraenoic acid is a potent inflammatory mediator and agonist of canine tracheal mucus secretion. Am Rev Respir Dis. 1985 Jun;131(6):917–922. doi: 10.1164/arrd.1985.131.6.917. [DOI] [PubMed] [Google Scholar]
  13. Labarca C., Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980 Mar 1;102(2):344–352. doi: 10.1016/0003-2697(80)90165-7. [DOI] [PubMed] [Google Scholar]
  14. Lees M. B., Paxman S. Modification of the Lowry procedure for the analysis of proteolipid protein. Anal Biochem. 1972 May;47(1):184–192. doi: 10.1016/0003-2697(72)90291-6. [DOI] [PubMed] [Google Scholar]
  15. Marcus A. J., Broekman M. J., Safier L. B., Ullman H. L., Islam N., Sherhan C. N., Rutherford L. E., Korchak H. M., Weissmann G. Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro. Biochem Biophys Res Commun. 1982 Nov 16;109(1):130–137. doi: 10.1016/0006-291x(82)91575-3. [DOI] [PubMed] [Google Scholar]
  16. Marcus A. J., Safier L. B., Ullman H. L., Broekman M. J., Islam N., Oglesby T. D., Gorman R. R. 12S,20-dihydroxyicosatetraenoic acid: a new icosanoid synthesized by neutrophils from 12S-hydroxyicosatetraenoic acid produced by thrombin- or collagen-stimulated platelets. Proc Natl Acad Sci U S A. 1984 Feb;81(3):903–907. doi: 10.1073/pnas.81.3.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moore S. A., Prokuski L. J., Figard P. H., Spector A. A., Hart M. N. Murine cerebral microvascular endothelium incorporate and metabolize 12-hydroxyeicosatetraenoic acid. J Cell Physiol. 1988 Oct;137(1):75–85. doi: 10.1002/jcp.1041370109. [DOI] [PubMed] [Google Scholar]
  18. Novikoff A. B., Novikoff P. M., Davis C., Quintana N. Studies on microperoxisomes. V. Are microperoxisomes ubiquitous in mammalian cells? J Histochem Cytochem. 1973 Aug;21(8):737–755. doi: 10.1177/21.8.737. [DOI] [PubMed] [Google Scholar]
  19. Pawlowski N. A., Scott W. A., Andreach M., Cohn Z. A. Uptake and metabolism of monohydroxy-eicosatetraenoic acids by macrophages. J Exp Med. 1982 Jun 1;155(6):1653–1664. doi: 10.1084/jem.155.6.1653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Poulos A., Sharp P., Whiting M. Infantile Refsum's disease (phytanic acid storage disease): a variant of Zellweger's syndrome? Clin Genet. 1984 Dec;26(6):579–586. doi: 10.1111/j.1399-0004.1984.tb01107.x. [DOI] [PubMed] [Google Scholar]
  21. Rabinovitch H., Durand J., Rigaud M., Mendy F., Breton J. C. Transformation of arachidonic acid into monohydroxy-eicosatetraenoic acids by mouse peritoneal macrophages. Lipids. 1981 Jul;16(7):518–524. doi: 10.1007/BF02535050. [DOI] [PubMed] [Google Scholar]
  22. Rhead W. J., Moon A., Roettger V., Henkle K. 14C-labeled substrate catabolism by human diploid fibroblasts derived from infants and adults. Biochem Med. 1985 Oct;34(2):182–188. doi: 10.1016/0006-2944(85)90109-7. [DOI] [PubMed] [Google Scholar]
  23. Sando G. N., Rosenbaum L. M. Human lysosomal acid lipase/cholesteryl ester hydrolase. Purification and properties of the form secreted by fibroblasts in microcarrier culture. J Biol Chem. 1985 Dec 5;260(28):15186–15193. [PubMed] [Google Scholar]
  24. Schepers L., Casteels M., Vamecq J., Parmentier G., Van Veldhoven P. P., Mannaerts G. P. Beta-oxidation of the carboxyl side chain of prostaglandin E2 in rat liver peroxisomes and mitochondria. J Biol Chem. 1988 Feb 25;263(6):2724–2731. [PubMed] [Google Scholar]
  25. Setty B. N., Graeber J. E., Stuart M. J. The mitogenic effect of 15- and 12-hydroxyeicosatetraenoic acid on endothelial cells may be mediated via diacylglycerol kinase inhibition. J Biol Chem. 1987 Dec 25;262(36):17613–17622. [PubMed] [Google Scholar]
  26. Setty B. N., Stuart M. J. 15-Hydroxy-5,8,11,13-eicosatetraenoic acid inhibits human vascular cyclooxygenase. Potential role in diabetic vascular disease. J Clin Invest. 1986 Jan;77(1):202–211. doi: 10.1172/JCI112277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shen X. Y., Figard P. H., Kaduce T. L., Spector A. A. Conversion of 15-hydroxyeicosatetraenoic acid to 11-hydroxyhexadecatrienoic acid by endothelial cells. Biochemistry. 1988 Feb 9;27(3):996–1004. doi: 10.1021/bi00403a024. [DOI] [PubMed] [Google Scholar]
  28. Singh I., Moser A. E., Goldfischer S., Moser H. W. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci U S A. 1984 Jul;81(13):4203–4207. doi: 10.1073/pnas.81.13.4203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Spector A. A., Gordon J. A., Moore S. A. Hydroxyeicosatetraenoic acids (HETEs). Prog Lipid Res. 1988;27(4):271–323. doi: 10.1016/0163-7827(88)90009-4. [DOI] [PubMed] [Google Scholar]
  30. Vanderhoek J. Y., Bryant R. W., Bailey J. M. Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. J Biol Chem. 1980 Nov 10;255(21):10064–10066. [PubMed] [Google Scholar]
  31. Vanderhoek J. Y., Karmin M. T., Ekborg S. L. Endogenous hydroxyeicosatetraenoic acids stimulate the human polymorphonuclear leukocyte 15-lipoxygenase pathway. J Biol Chem. 1985 Dec 15;260(29):15482–15487. [PubMed] [Google Scholar]
  32. Wanders R. J., van Roermund C. W., van Wijland M. J., Schutgens R. B., Heikoop J., van den Bosch H., Schram A. W., Tager J. M. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders. J Clin Invest. 1987 Dec;80(6):1778–1783. doi: 10.1172/JCI113271. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES